News · Supplements
A selenium supplement lowered long-term blood sugar by 1.2 points in eight weeks
That is a drug-sized change from a mineral sold in pharmacies. It came from one small trial in patients with diabetic nerve damage, and the size of the effect is the reason to be careful rather than excited.
- Long-term blood sugar fell by about 1.2 points, which is as much as some drugs deliver.
- Fasting blood sugar fell substantially too.
- The trial ran eight weeks in patients who also had diabetic nerve damage.
- An effect that large from a mineral is a reason for caution, not enthusiasm.
- Selenium is toxic above a fairly low ceiling, and more is not better.
There is a rule of thumb worth applying to supplement research: the more impressive the result, the more carefully you should read the methods.
A trial in the European Journal of Nutrition reports that eight weeks of organic selenium supplementation significantly improved glycemic indices in patients with type 2 diabetes and nerve damage. The size of the improvement is what makes it worth writing about, and what makes it hard to believe.
Long-term blood sugar fell by about 1.2 points. That is the territory of prescription drugs.
What was measured
Two things moved. Fasting blood sugar dropped by roughly 34 points on the standard scale, with a range wide enough to reach almost to zero at one end.
HbA1c, which reflects average blood sugar over the previous two to three months, fell by about 1.2 percentage points.
For comparison, metformin is the drug every guideline reaches for first in type 2 diabetes, and it typically delivers a reduction of around 1 to 1.5 points. A mineral available without prescription matching that in eight weeks would be a significant finding in the literal sense.
Why a big number in a small trial should make you cautious
This is the part most coverage of supplement trials leaves out.
Small studies do not produce more modest results than large ones. They produce noisier ones, spread more widely around the truth, and a small study only crosses the threshold for publication if its estimate lands at the high end of that spread.
The consequence is systematic. Among published small trials, the average reported effect is larger than the real effect, and larger trials of the same question routinely report smaller numbers. This is not a criticism of any individual study; it is a property of how the literature assembles itself.
An unusually large effect from a small trial is therefore weak evidence of a large effect and reasonable evidence that something is worth testing properly.
Eight weeks is the other limit
HbA1c measures the previous two to three months. A trial lasting eight weeks is measuring a marker that has barely finished responding to the intervention.
Diabetes is also managed over decades. Whether a change at eight weeks persists, whether the body adapts, and whether anything happens to the outcomes that actually matter, namely nerves, kidneys, eyes and hearts, are questions no eight-week trial can address.
Selenium is not a harmless thing to take more of
Most nutrients have a wide safety margin. Selenium does not.
It is an essential trace mineral with a tolerable upper limit that sits uncomfortably close to ordinary dietary intake, and exceeding it produces a recognizable syndrome: hair and nail loss, garlic breath, gastrointestinal upset, and, with some irony given the patients in this trial, nerve damage.
Selenium supplements have also been associated with higher rather than lower diabetes risk in some earlier work, which is the opposite of the direction reported here and a reason not to treat the question as settled.
Who the patients were
Everyone in the trial had type 2 diabetes complicated by peripheral neuropathy. Diabetic neuropathy is nerve damage that most often affects the feet and legs, and it develops when high blood sugar injures nerves over years.
That is a specific and unwell population, not the general public, and results in people with advanced complications do not automatically transfer to someone with well-controlled diabetes or none at all.
The trial reports no notable adverse effects over eight weeks, which is reassuring about the short term and says nothing about a mineral taken indefinitely.
What would make this believable
A larger trial, running longer, reporting whether participants were selenium-deficient to begin with.
That last point is the crux. Supplement trials that succeed often succeed because the population was short of the nutrient, in which case the finding is about correcting a deficiency rather than about selenium having a glucose-lowering property. Those are different claims with different implications for anyone reading about them.
Until that trial exists, the honest summary is that a mineral produced a drug-sized effect in a small short study, and that the most likely explanation for a drug-sized effect from a mineral is that the study was small and short.
People also ask
What did the trial find?
Selenium supplementation significantly reduced fasting blood sugar (adjusted mean difference -33.95 mg/dL; 95% CI -64.2 to -5.5; P = 0.021) and HbA1c (adjusted mean difference -1.20%; 95% CI -1.79 to -0.61), over eight weeks, without notable adverse effects.
How big is a 1.2 point change in HbA1c?
Large. Metformin, the standard first-line diabetes drug, typically lowers it by about 1 to 1.5 points. A mineral supplement matching that in eight weeks would be remarkable, which is precisely why it needs replication before anyone believes it.
Why be sceptical of a large effect?
Because effect sizes in small trials are systematically inflated. A trial only reaches significance if its estimate is big enough, so among small studies the ones that get published overstate the true effect. Bigger trials almost always report smaller numbers.
Is selenium safe to take?
It has a narrow window. It is an essential trace mineral and it is toxic in excess, with a tolerable upper limit far closer to typical intake than for most nutrients. Selenium toxicity causes hair and nail loss, gastrointestinal upset and nerve problems.
Does more selenium help people who are not deficient?
That is the unanswered question. Supplement trials that work often work because the population was short of the nutrient. The trial reports the effect, not whether the patients started deficient.
What is diabetic peripheral neuropathy?
Nerve damage caused by long-term high blood sugar, usually starting in the feet, producing numbness, burning or pain. It is a leading cause of foot ulcers and amputation.
Should anyone start taking selenium?
No. This is one small short trial, selenium has a real toxicity ceiling, and diabetes medication should not be supplemented around without the prescriber knowing. This is general information rather than medical advice.